TINA COCHRAN: Open Payments
NPI 1265904825 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,867 in 62 payments from 16 companies in 2025. Trend: 2023 $2,045 · 2024 $2,253 · 2025 $1,867
Food & beverage: $1,867
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $417 |
| Otsuka America Pharmaceutical, Inc. | 9 | $337 |
| Amgen Inc. | 8 | $268 |
| AstraZeneca Pharmaceuticals LP | 3 | $160 |
| Vanda Pharmaceuticals Inc. | 6 | $158 |
| Novo Nordisk Inc | 5 | $147 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $108 |
| Merck Sharp & Dohme LLC | 4 | $70 |
| Lilly USA, LLC | 3 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
Products named: REXULTI, VRAYLAR, QULIPTA, FANAPT, AIRSUPRA, EVENITY, Ozempic, REPATHA.
Industry payments across AL — which companies pay providers there.
